Veradigm | MDRX - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Alcidion AUD 1.56M 1.77M 2025-12
Ambu A/S DKK 157M 4M 2026-03
Amplifon EUR 23.22M 3.12M 2026-03
Cardinal Health USD 782M 390M 2026-06
Centene USD 1.49B 613M 2026-06
Charles River Laboratories USD -29.94M 264.16M 2026-03
Cigna USD 2.27B 453M 2026-03
Coloplast 1.79B 236M 2025-12
Convatec Group USD 52M 6.3M 2024-06
CVS Health USD 3.94B 2.58B 2026-03
Diasorin EUR 62M 11.45M 2026-03
Elevance Health USD 2.16B 146M 2026-06
General Electric Aerospace USD 2.2B 654M 2026-03
Humana USD 1.6B 2.61B 2026-03
IQVIA Holdings USD 301M 5.92B 2026-06
Laboratory Of America USD 8.61B 121.8M 2026-06
Maximus USD 138.16M 11.62M 2026-06
McKesson USD 2.12B 495M 2026-03
Med Life RON 15.94M 4.07M 2026-03
Molina Healthcare USD 112M 83M 2026-06
Omnicell USD 16.9M 16.21M 2026-03
Oriola-kd EUR 2.2M 7.8M 2025-09
Owens Minor USD 35.71M 5.37M 2025-09
Quest Diagnostics USD 334M 4M 2026-03
Rede D'or Sao Luiz BRL 1.42B 74.95M 2026-03
Siemens Healthineers EUR 644M 41M 2026-03
Sonova Holding CHF 234.3M 159.4M 2025-12
Supermax Corporation Bhd MYR -39.65M 103.39M 2026-03
UnitedHealth USD 7.36B 600M 2026-06
Veeva Systems USD 469.79M 152.26M 2026-03
Veradigm USD 35.3M 13.95M 2022-09
Xerox USD 323M 24M 2026-06